Bone Biologics Corporatio... (BBLGW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
59.20
-8.80 (-12.94%)
At close: Jan 14, 2025, 9:00 PM
67.35
13.77%
Pre-market Jan 15, 2025, 11:09 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Net Income | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.88M | -4.42M | -1.08M | -715.57 | -3.60K | -49.05K | -10.29K | -13.34K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 280.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 152.60K | 266.63K | 207.03K | 60.00K | 49.69K | 516.64K | -584.03K | 3.46M | 3.70M | 256.64K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -122.95K | -956.92K | 45.00K | 66.68K | 208.61K | 212.45K | 938.74K | 71.14K | -106.48K | -903.32K | 35.25K | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | -892.69K | -2.18M | 495.55K | 938.08K | 257.81K | 380.03K | 3.37M | 4.01M | 6.04M | 1.41M | 521.59K | 268.08 | -2.08K | 3.60K | 5.41K | -10.98K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -277.75K | -716.79K | n/a | 6.09M | 498.87K | 909.46K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 132.92K | -168.37K | -320.49K | 399.68K | 143.78K | 145.54K | 938.74K | 144.48K | 87.98K | -903.32K | 35.25K | n/a | n/a | n/a | n/a | n/a |
Operating Cash Flow | -9.56M | -3.57M | -1.23M | -426.93K | -3.25M | -4.10M | -3.33M | -7.33M | -3.55M | -2.76M | -525.37K | -447.49 | -5.68K | -45.45K | -4.87K | -24.33K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -504 | -11.90K | n/a | n/a | n/a | n/a | n/a | n/a |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.38K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.38 | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -504 | 25.48K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 1.05M | 402.79K | 2.32M | n/a | 2.70M | 3.08M | 2.00M | 4.91M | 524.53K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | n/a | n/a | n/a | 448.61 | 5.68K | 45.45K | 1.79K | 15.30K |
Financial Cash Flow | 5.04M | 4.43M | 7.90M | 402.79K | 2.32M | 4.37M | 3.40M | 6.83M | 2.00M | 5.39M | 524.53K | 448.61 | 5.68K | 45.45K | 1.79K | 15.30K |
Net Cash Flow | -4.51M | 862.95K | 6.68M | -24.14K | -931.23K | 265.10K | 69.90K | -494.73K | -1.55M | 2.66M | 1.04K | 1.12 | n/a | n/a | -3.08K | -9.02K |
Free Cash Flow | -9.56M | -3.57M | -1.23M | -426.93K | -3.25M | -4.10M | -3.33M | -7.33M | -3.55M | -2.77M | -525.37K | -447.49 | -5.68K | -45.45K | -4.87K | -24.33K |